H.I.G. Capital LLC (H.I.G Capital) is a private equity investment firm. It offers both debt and equity capital to small and mid-sized companies in Europe, Latin America, and the US. It operates through offices in the US, the UK, France, Italy, Luxembourg, Colombia, Germany, Spain, and Brazil. The company has over US$69 billion of assets under management. The company’s fund portfolio comprises private equity, growth equity, Infrastructure, real estate, credit, and biohealth. H.I.G. Private Equity funds of H.I.G. Capital focuses on leveraged buyouts, equity, debt, and other investments in small- and mid-sized companies. The company has invested in and managed more than 400 companies globally, with combined sales more than US$53 billion. H.I.G. Growth Equity is the growth capital investment affiliate of H.I.G. Capital. It makes both majority and minority investments in strong, growth-oriented businesses located throughout North America, South America, and Europe. The company primarily invests in SAAS, cloud & data software, internet, technology-enabled services, and digital marketing services, consumer or e-commerce, and healthcare. The company invests in real estate assets through its affiliate, H.I.G. Realty Partners, which invests small-and mid-size real estate properties in the US, Europe, and Latin America. It has completed real estate investments of above US$7 billion in value. Through its credit arm, WhiteHorse Capital, the company provides direct lending to middle-market companies in the US and Europe. It has a broad investment mandate and offers senior and subordinated debt for buyouts, growth capital, refinancing, acquisitions, and balance sheet recapitalization. H.I.G. Capital through Bayside Capital provides access to debt and equity capital, in partnership with existing stakeholders and trades in public and private debt instruments in the secondary market. The company through its infrastructure arm, H.I.G. Infrastructure makes value-add and core plus investments in the infrastructure sector. It principally targets mid-market opportunities to enhance its value creation. It operates in North America and Europe. The company’s affiliate H.I.G. BioHealth Partners invests in a broad range of life sciences companies across sectors and stages. It invests in biopharmaceutical and medical technology companies for developing novel products for significant unmet medical needs.